ArabFinance: Alexandria Company for Pharmaceuticals and Chemical Industries (Alex Pharma) (AXPH) reported a 27.45% year-on-year (YoY) decline in net profit after tax for the first half (H1) of fiscal year (FY) 2021/2022, according to the companys unaudited financial indicators filed to the Egyptian Exchange (EGX).

Net profit after tax amounted to EGP 57.32 million in H1 FY 2021/2022, compared to a profit of EGP 79.005 million in H1 FY 2020/2021.

Revenue slipped by 0.51% YoY to EGP 577.26 million in the July-December period of 2021 from EGP 580.22 million in the same period of 2020.

It is worth noting that the company achieved a net profit after tax of EGP 45.38 million in the first five months of fiscal year (FY) 2021/2022, down by 30% YoY from EGP 64.80 million.

Alex Pharma, a subsidiary of Drug Holding Company, is an Egypt-based company engaged in the manufacture, development, and marketing of pharmaceutical, chemical, veterinary, and nutritional food products, as well as medical appliances.

Copyright 2022 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an as is and as available basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.